NCT Number: NCT05168761
Complications Associated With Partial Nephrectomy for Renal Cancer
This paper evaluates the initial complications and the complications two years postoperatively necessitating re-hospitalisation for three surgical procedures for renal tumour partial nephrectomy .
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
About this study
This paper evaluates the initial complications and the complications two years postoperatively necessitating re-hospitalisation for three surgical procedures for renal tumour partial nephrectomy (open (OPN), standard laparoscopy (LPN) and robot assisted laparoscopy (RAPN)) in 2016-2017 in France (9119 initial hospitalisations included 4035 OPN, 1900 RAPN, 1709 LPN). The investigators have extracted for these all hospitalisations from the French national hospital data base (PMSI-MCO). The investigators concluded mini-invasive and robotic surgery had lower morbidity and a shorter initial hospitalisation.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- hospitalisations between the 1st January 2016 and the 31st December 2017 with one of the partial nephrectomy codes
Exclusion criteria
- partial nephrectomy for non-cancerous pathology
- no technical information
Treatment and study plan
Primary outcomes
-
post operative complication
Time frame: 2 years
Complications were documented for the initial hospitalisation and any subsequent re-hospitalisation
Secondary outcomes
-
length of initial hospitalisation
Time frame: 2 years
length of initial hospitalisation
Sponsors and collaborators
Lead sponsor
Central Hospital, Nancy, France
Other
Registry information
Official study title
Complications Associated With Partial Nephrectomy for Renal Cancer: PMSI French National Data
Important dates
- Study start
- 2016
- Primary completion
- 2018
- Study completion
- 2019
- First posted
- Dec 23, 2021
- Registry last updated
- Jan 13, 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Navigated Partial Nephrectomy
NCT07315100
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amsterdam, North Holland, Netherlands
View Trial DetailsA Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
NCT03289962
Bladder Cancer, Breast Diseases
Scottsdale, Arizona, United States
View Trial DetailsVaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
NCT00458536
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Boston, Massachusetts, United States
View Trial DetailsMultiparametric MRI for Diagnosing Small Renal Tumors
NCT03470285
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Angers, France
View Trial Details